Author:
Cheng Qi,Cheng Jinluo,Cordato Dennis,Gao Jianqun
Subject
Pharmacology (medical),Pharmacology
Reference151 articles.
1. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus;Aaboe;Diabetes, Obesity & Metabolism,2010
2. Neuroprotective effects of vildagliptin in rat rotenone Parkinson’s disease model: Role of RAGE-NFkappaB and Nrf2-antioxidant signaling pathways;Abdelsalam;Journal of Neurochemistry,2015
3. Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo;Ahmad;The Journal of Pharmacology and Experimental Therapeutics,1992
4. DPP-4 inhibition and the path to clinical proof;Ahren;Front Endocrinol (Lausanne),2019
5. Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study;Ahtiluoto;Neurology,2010
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献